Acta Neuropathol

1. RAHMANZADE R, Schweizer L, Schmid S, Lausova T, et al
   Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.
   Acta Neuropathol. 2026;151:46.
   

   >> Share

   
   

   
   Childs Nerv Syst

2. SHAH KH, Guerrero-Ocampo MJ, Flecha IG, Roach CS, et al
   Impact of chemotherapy and immunotherapy on survival in pediatric primary diffuse leptomeningeal melanomatosis: a systematic review and pooled survival analysis.
   Childs Nerv Syst. 2026;42:189.
   

   >> Share

   
   
3. CHIMATIRA R
   Rosette-forming glioneuronal tumor of the cerebellum with intratumoral hemorrhage: case report with radiologic-pathologic correlation in a resource-limited setting.
   Childs Nerv Syst. 2026;42:186.
   

   >> Share

   
   

   
   Clin Cancer Res

4. XU Q, Huang K, Meng X, Weng Y, et al
   Retraction: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.
   Clin Cancer Res. 2026;32:1913.
   

   >> Share

   
   
5. TIU C, Yau W, Silva D, Waldron N, et al
   Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastoma.
   Clin Cancer Res. 2026 Apr 27. doi: 10.1158/1078-0432.CCR-25-4364.
   

   >> Share

   
   
6. WILLIAMS MM, Haskell-Mendoza AP, Massat EA, Mott BT, et al
   Contemporary Management of Radiation Necrosis: Insights and Avenues.
   Clin Cancer Res. 2026;32:1606-1614.
   

   >> Share

   
   
7. GRIGUOLO G, Bottosso M, Landa G, Bonomi G, et al
   Proactive brain screening using contrast-enhanced brain CT scans in HER2+ metastatic breast cancer.
   Clin Cancer Res. 2026 Feb 9. doi: 10.1158/1078-0432.CCR-25-3557.
   

   >> Share

   
   
8. LEE EJ, Ko JA, Kim MJ, Cho JS, et al
   JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC.
   Clin Cancer Res. 2026;32:1835-1845.
   

   >> Share

   
   

   
   Int J Cancer

9. SALIM SK, Shaikh MV, Wei J, Maich WT, et al
   Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma.
   Int J Cancer. 2026 Apr 24. doi: 10.1002/ijc.70509.
   

   >> Share

   
   

   
   Int J Radiat Oncol Biol Phys

10. WISDOM AJ, Temple H, Cui Y, Vecchio CTD, et al
    Mechanisms, Microenvironments, and Models: Understanding Therapeutic Resistance in Glioblastoma.
    Int J Radiat Oncol Biol Phys. 2026 Apr 22:S0360-3016(26)00587.
    

    >> Share

    
    

    
    J Neurooncol

11. GAGLIARDI F, De Domenico P, Roncelli F, Snider S, et al
    Circulating Angiopoietin-1/Angiopoietin-2 ratio may reflect pre- and post-treatment vascular states in Glioblastoma and improve discrimination between tumor recurrence and radiation necrosis.
    J Neurooncol. 2026;177:123.
    

    >> Share

    
    
12. MAURICAITE R, Calvez KL, Robinson SD, Camp S, et al
    Variation in rates of post-operative oncological treatment for patients with glioblastoma in England: a comprehensive multi-year National cohort study from the GlioCova project.
    J Neurooncol. 2026;177:126.
    

    >> Share

    
    
13. FRIEDES C, Berger M, Linkowski L, Hollawell C, et al
    Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
    J Neurooncol. 2026;177:125.
    

    >> Share

    
    
14. MA Y, Zhou R, Ma Y, Mou C, et al
    Application of multidimensional cognitive training in the early postoperative period for glioma patients with cognitive impairment.
    J Neurooncol. 2026;177:128.
    

    >> Share

    
    
15. GOULENKO V, Sinha S, Gulzar B, Madhugiri VS, et al
    Longitudinal remodeling of brain metastasis resection cavities after adjuvant gamma knife radiosurgery.
    J Neurooncol. 2026;177:129.
    

    >> Share

    
    
16. GOODIN DA, Chen J, Williams BJ, Frieboes HB, et al
    Glioblastoma region-specific metabolic signatures reflect patient survival duration.
    J Neurooncol. 2026;177:130.
    

    >> Share

    
    

    
    J Neuropathol Exp Neurol

17. HIGA N, Akahane T, Yokoyama S, Yonezawa H, et al
    Molecular and clinical prognostic factors in isocitrate dehydrogenase-mutant astrocytomas: Insights into biomarker-driven stratification.
    J Neuropathol Exp Neurol. 2026;85:455-463.
    

    >> Share

    
    

    
    J Neurosurg

18. LUO C, Song Y, Zhu G, Zhang X, et al
    The efficacy and safety of sublobectomy for glioblastoma: a propensity score-weighted study.
    J Neurosurg. 2026 Apr 24:1-14. doi: 10.3171/2025.12.JNS251341.
    

    >> Share

    
    
19. LEE KE, Catapano JS, Eschbacher JM, Rogers CL, et al
    Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants for recurrent aggressive meningiomas: 5-year results from a prospective phase 2 trial.
    J Neurosurg. 2026 Apr 24:1-8. doi: 10.3171/2025.12.JNS25868.
    

    >> Share

    
    

    
    Neuro Oncol

20. FEDERICO A, Schmitt-Hoffner F, Fonseca A, Geisemeyer N, et al
    Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies.
    Neuro Oncol. 2026;28:1005-1019.
    

    >> Share

    
    
21. DARLIX A, Bady P, Deverdun J, Bars EL, et al
    Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas.
    Neuro Oncol. 2026;28:911-922.
    

    >> Share

    
    
22. RAJAN S, Chung HJ, Wu Z, Singh O, et al
    Intracranial mesenchymal tumor, FET::CREB fusion-positive: An integrative analysis of 81 cases.
    Neuro Oncol. 2026;28:939-951.
    

    >> Share

    
    
23. YANG C, Cai H, Liu W, Wang J, et al
    Cerebrospinal fluid metabolomics and machine learning identify novel biomarkers for lung cancer leptomeningeal metastasis.
    Neuro Oncol. 2026;28:980-993.
    

    >> Share

    
    
24. OZDEMIR Z, Gallus M, Muther M, Stummer W, et al
    5-ALA-mediated PpIX Accumulation in the Tumor Microenvironment of Glioma and its Implications for 5-ALA-based Local Tumor Therapies: A Review of the Literature.
    Neuro Oncol. 2026 Apr 30:noag094. doi: 10.1093.
    

    >> Share

    
    

    
    Neuroradiology

25. REYES JS, Almeida T, Bouras A, Mettenburg J, et al
    Radiomics-based artificial intelligence models in brain tumors: A systematic review and meta-analysis of diagnostic performance.
    Neuroradiology. 2026 Apr 27. doi: 10.1007/s00234-026-03983.
    

    >> Share

    
    

    
    Neurosurgery

26. YURTLUK MD, Wei CZ, Reyes JS, Puccio D, et al
    Primary Versus Adjuvant Stereotactic Radiosurgery for Cavernous Sinus Meningiomas: A Propensity Score-Matched Comparative Analysis.
    Neurosurgery. 2026 Apr 30. doi: 10.1227/neu.0000000000004071.
    

    >> Share

    
    

    
    PLoS Genet

27. ZHOU L, Che H, Jiang H, Yin L, et al
    Nebivolol suppresses glioblastoma progression via dual modulation of mitochondrial metabolism and AKT/mTOR/4EBP1 signaling axis.
    PLoS Genet. 2026;22:e1012120.
    

    >> Share

    
    

    
    PLoS One

28. AL-ROBAIY S, Hohmann U, Simm A, Dehghani F, et al
    An optimized protocol for metabolic measurement in 3D tumor spheroids derived from primary and established glioblastoma cells.
    PLoS One. 2026;21:e0347569.
    

    >> Share

    
    

    
    Radiol Artif Intell

29. FATHI KAZEROONI A, Jiang Z, Gandhi D, Khalili N, et al
    Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas.
    Radiol Artif Intell. 2026 Apr 29:e250902. doi: 10.1148/ryai.250902.
    

    >> Share

    
    
30. LEE J, Jeon YH, Jang J, Eum H, et al
    Deep Learning for Survival Prediction in Glioblastoma: Time-dependent Model Interpretability Using MRI, Clinical, and Molecular Data.
    Radiol Artif Intell. 2026 Apr 29:e250675. doi: 10.1148/ryai.250675.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share